source
- Genetix Biotherapeutics reports $327M YTD sales and projects $500M full-year revenue, marking profitabilityGenetix Biotherapeutics, the former bluebird bio, announced that it has become profitable, reporting $327 million in U.S. net sales year‑to‑date and forecasting total 2026 sales of about $500 milli…
- AI drugmaker Isomorphic Labs raises $5 billion in Series C roundIsomorphic Labs, an Alphabet spinout that applies artificial intelligence to drug discovery, announced a $5 billion Series C financing. The round was led by Greenoaks and Sequoia Capital, with Alp…